![Francis Lo](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 4 M $ in data 31/05/2026
Francis Lo is currently Chief People Officer at Adaptive Biotechnologies Corp.
since 2019.
Formerly, Mr. Lo was Vice President-Human Resources at Whole Foods Market, Inc. from 2017 to 2019 and Director-Global Talent Management at Starbucks Corp.
from 2015 to 2017.
Education includes an undergraduate degree from The University of Texas at Austin and an MBA from Stanford Graduate School of Business.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 02/07/2026 | 233.213 ( 0,15% ) | 4 M $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| ADAPTIVE BIOTECHNOLOGIES CORPORATION | Ufficiale delle Risorse Umane | 01/05/2019 |
| Società | Posizione | Fine |
|---|---|---|
| WHOLE FOODS MARKET, INC. | Ufficiale delle Risorse Umane | 01/04/2019 |
| STARBUCKS CORPORATION | Corporate Officer/Principal | 01/03/2017 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 5 |
|---|---|
Starbucks Corp.
 Starbucks Corp. RestaurantsConsumer Services Produces and sells coffee and tea | Consumer Services |
Whole Foods Market, Inc.
 Whole Foods Market, Inc. Food RetailRetail Trade Owns and operates natural & organic food supermarkets | Retail Trade |
The University of Texas at Austin
 The University of Texas at Austin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stanford Graduate School of Business
 Stanford Graduate School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Adaptive Biotechnologies Corp.
 Adaptive Biotechnologies Corp. BiotechnologyHealth Technology Develops minimal residual disease and immune medicine | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
